Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics
Yahoo/BusinessWire
Saturday, July 21, 2012 - 11:46am
tags:
Spectrum Pharmaceuticals, Allos, M&A
Ampio Pharmaceuticals Expands Pipeline with Promising New Cancer Drug NCE001
Motley Fool
Saturday, July 21, 2012 - 11:42am
tags:
Ampio Pharmaceuticals, NCE001, breast cancer, renal cancer, glioblastoma multiforme
Ligand Pharmaceuticals confirms FDA accelerated approval of Kyprolis
The Fly on the Wall
Saturday, July 21, 2012 - 11:39am
tags:
Ligand Pharmaceuticals, Kyprolis, Multiple Myeloma
Gilead Sciences Inc (GILD): Today's Featured Health Care Laggard
The Street
Saturday, July 21, 2012 - 11:38am
tags:
Gilead Sciences
Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Leader
The Street
Saturday, July 21, 2012 - 11:37am
tags:
Questcor Pharmaceuticals
Trovagene: Technology In A Cup?
Seeking Alpha
Saturday, July 21, 2012 - 11:36am
tags:
TrovaGene
Medivation Inc.: Today's Featured Health Care Leader
The Street
Saturday, July 21, 2012 - 11:33am
tags:
Medivation
UniQure’s Glybera Wins EU Backing As First Gene Therapy
Bloomberg
Saturday, July 21, 2012 - 11:30am
tags:
uniQure, Glybera
Onyx Wins U.S. FDA Approval For Blood Cancer Treatment
Bloomberg
Saturday, July 21, 2012 - 11:27am
tags:
ONYX Pharmaceuticals, Kyprolis, Multiple Myeloma
Vivus falls on concerns of patent protection for diet pill
Reuters
Friday, July 20, 2012 - 10:42am
tags:
Vivus, Qsymia, patents
Court upholds Pfizer's Lyrica patent protection
Reuters
Friday, July 20, 2012 - 10:40am
tags:
Pfizer, generics, patents, Lyrica
Cubist Increases Revenue 30% to $231 Million in the Second Quarter
Yahoo
Friday, July 20, 2012 - 10:34am
tags:
earnings, Cubist
Amarin Shares Trade Higher on Hope for Fish-Oil Drug
Minyanville
Friday, July 20, 2012 - 10:33am
tags:
AMR-101, Amarin, fish oil
Biogen Idec Second Quarter Earnings Preview
Investopedia.com
Friday, July 20, 2012 - 10:31am
tags:
BiogenIdec, earnings
Merck: Experts In Patent Cliff Management
Motley Fool
Friday, July 20, 2012 - 10:31am
tags:
patents, Merck, patent cliff
Report: J&J will pay as much as $2.2B to resolve investigation of Risperdal marketing
Yahoo/AP
Friday, July 20, 2012 - 10:28am
tags:
JNJ, Risperdal, settlements
Merck: New Sleeping Pill Thwarts Brain’s Up-All-Night Neurons
Bloomberg
Friday, July 20, 2012 - 9:33am
tags:
Merck, insomnia, orexin receptors, GSK, Takeda
The Market Has Already Discounted Merck's New Drug
Seeking Alpha
Friday, July 20, 2012 - 9:30am
tags:
Merck, Abbott Labs, Amgen, GSK, Pfizer, Eli Lilly, osteoporosis, Odanacatib
Roche’s Secret Heart Drug Moves Toward Late-Stage Trial
Bloomberg
Friday, July 20, 2012 - 9:29am
tags:
Roche, Sanofi, PCSK9 inhibitor, Regeneron, Amgen
Pfizer's Crizotinib receives positive opinion from CHMP
Yahoo/Fly on the Wall
Friday, July 20, 2012 - 9:26am
tags:
Pfizer, crizotinib, CHMP, small cell lung cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.